Weber S, Kahan A, Pailleret J J, Guérin F, Degeorges M
Ann Cardiol Angeiol (Paris). 1983 Dec;32(8):545-9.
A test provocation of coronary artery spasm by alkalosis was used to evaluate a possible anti-coronary artery spasm effect of molsidomine. The rapid infusion of an alkaline buffer followed by maximal voluntary hyperventilation in 10 patients with angina at rest led to the appearance of angina pain and significant, transient ischaemic changes of the ST segment, due to alkalosis induced coronary spasm. A second provocation test was performed under the same conditions, 24 hours later, after the prior administration of 4 mg of molsidomine. Molsidomine prevented the development of coronary artery spasm in 8 of the 10 patients in the study group. These preliminary results justify further clinical evaluation of molsidomine in the treatment of vasospastic angina.
采用碱中毒诱发冠状动脉痉挛试验来评估吗多明对冠状动脉痉挛的可能抗痉挛作用。对10例静息性心绞痛患者快速输注碱性缓冲液,随后进行最大自主过度通气,由于碱中毒诱发冠状动脉痉挛,导致心绞痛发作以及ST段显著短暂性缺血改变。24小时后,在预先给予4毫克吗多明后,于相同条件下进行第二次激发试验。在研究组的10例患者中,吗多明预防了8例患者冠状动脉痉挛的发生。这些初步结果证明对吗多明治疗血管痉挛性心绞痛进行进一步临床评估是合理的。